GOTEBORG, Sweden, April 22, 2021 /PRNewswire/ — Today, Getinge announces clearance from the US FDA of several new software options for the Servo-u and Servo-n ventilators. In addition to the latest ...

(HealthDay News) — For patients with heart failure with reduced ejection fraction and predominantly central sleep apnea, adaptive servo-ventilation does not improve outcome, according to a study ...

The Maquet SERVO-i ventilator battery module has been recalled due to the battery having a shorter run time than expected, according to the American Society of Anesthesiologists. The FDA assigned a ...

WAYNE, New Jersey, July 7, 2020 /PRNewswire/ -- US Food & Drug Administration (FDA) clears Servo-air® mechanical ventilator for use with adult and pediatric patients dependent on intensive care ...

To the Editor: Cowie et al. (Sept. 17 issue) 1 report on the results of the Treatment of Sleep-Disordered Breathing with Predominant Central Sleep Apnea by Adaptive Servo Ventilation in Patients with ...

GETINGE, Sweden, April 10, 2019 /PRNewswire/ -- Getinge is today announcing clearance from the US Food & Drug Administration (FDA) for a new software version for the Servo-u® and Servo-n® mechanical ...

ORLANDO, Fla. — In a substudy of CAT-HF, patients with HF, sleep-disordered breathing and an implantable cardiac device assigned adaptive servo-ventilation plus optimal medical therapy had a reduction ...

The Maquet Getinge Group is recalling 90,000 defective batteries used with the SERVO-i ventilator system, the US Food and Drug Administration (FDA) announced May 7. The FDA said some battery modules ...

Mumbai: Getinge announced the launch of its cutting-edge Servo-c mechanical ventilator to the Indian market. The Servo-c is designed to address the diverse respiratory needs of both paediatric and ...